Raising Health AI Revolution with Daphne Koller
Oct 3, 2023
Daphne Koller, founder and CEO at insitro and AI expert, discusses the use of AI in life sciences, including the POSH approach for potential therapeutic interventions. They also explore the power of AI in analyzing cellular images and clinical data, and the challenges of merging biology and ML AI.
AI Snips
Chapters
Transcript
Episode notes
Why Life Sciences?
- Daphne Koller chose life sciences because it presents a hard, important problem.
- She believes AI can be used for good in this field.
AI in Life Sciences: Why Now?
- Advancements in data generation at scale, especially at the cellular level, are key to applying AI effectively in life sciences.
- Koller's company, insitro, leverages a data factory to generate biological data on demand.
POSH Platform Example
- Koller describes insitro's POSH platform (pooled optical screening in humans), allowing large-scale CRISPR screens.
- This platform helps understand gene-phenotype connections by analyzing cellular behavior after genetic modifications.